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Immune responseImmune responses to pathogens are regulated by immune receptors containing either an immunoreceptor
tyrosine-based activation motif (ITAM) or an immunoreceptor tyrosine-based inhibitory motif (ITIM).
The important diarrheal pathogen enteropathogenic Escherichia coli (EPEC) require delivery and insertion
of the bacterial translocated intimin receptor (Tir) into the host plasma membrane for pedestal formation.
The C-terminal region of Tir, encompassing Y483 and Y511, shares sequence similarity with cellular ITIMs.
Here, we show that EPEC Tir suppresses the production of inﬂammatory cytokines by recruitment of SHP-2
and subsequent deubiquitination of TRAF6 in an ITIM dependent manner. Our ﬁndings revealed a novel
mechanism by which the EPEC utilize its ITIM motifs to suppress and evade the host innate immune re-
sponse, which could lead to the development of novel therapeutics to prevent bacterial infection.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-SA license. 1. Introduction
Immune responses are usually positively regulated by receptors
containing an immunoreceptor tyrosine-based activation motif (ITAM)
or negatively regulated by receptors containing an immunoreceptor
tyrosine-based inhibitory motif (ITIM) [1]. When the receptors are acti-
vated by their ligands, the tyrosine residues within their ITAMs will be
rapidly phosphorylated, thereby forming the docking sites for several
SH2-domain containing cellular proteins including Src family protein
tyrosine kinases (PTK) such as Zap-70, Syk and other adaptormolecules
to transduce a downstream signaling cascade by phosphorylating vari-
ous effector molecules [2,3]. Many immune responses are mediated
by ITAMs, such as phagocytosis, antibody-dependent cellular cytoxicity
(ADCC), cytokine production, superoxide release and antigen presen-
tation [4]. Conversely, activated immune responses are negativelyes, Shanghai Institutes for Bio-
ai Jiaotong University School of
nc. Open access under CC BY-NC-SA licregulated by ITIM-containing receptors [1,5]. Inhibitory activity of
ITIM-containing receptors functions upon co-crosslinking with an
ITAM-containing receptor and the inhibitory mechanism depends
on the phosphorylation of the tyrosine in the ITIM by an ITAM-
related PTK [6,7]. Tyrosine phosphorylation of ITIMs forms binding
sites for SH2 containing cellular phosphatase such as protein tyrosine
phosphatases SHP-1 or SHP-2. These phosphatases then decrease the
phosphorylation of Syk, PLCγ, BLNK/SLP-76, VAV-1, Jak2, ZAP70, the
γ-chain of the CD16 complex, or a series of downstream signals to
inhibit the host immune response.
Interestingly, several bacterial proteins, such as Tir and CagA from
Helicobacter pylori, contain regions that share sequence similarities
with the host ITIMs [8]. Upon Src phosphorylation of these ITIM-like
sequences, CagA recruits SHP-2 to stimulate tyrosine-phosphatase
activity, which results in changes of the cell morphology [9]. The
ITIM of the EPEC Tir is also shown to recruit the cellular inositol phos-
phatase SHIP2 to regulate actin-pedestal formation [10]. Recently,
it has been shown that Tir interacts with SHP-1 and facilitates the
recruitment of SHP-1 to TRAF6, thus inhibiting the ubiquitination of
TRAF6 and subsequent expression of the proinﬂammatory cytokines.
However, little is known about the role of the Tir and SHP-2 in the
regulation of host immune responses. Therefore, we sought to ex-
plore whether the tyrosine residues within the Tir ITIM sequences
play an important role in regulating host innate immune responses
through SHP-2.ense. 
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2.1. Cell culture and reagents
RAW264.7 cells and HEK293T cells were maintained in Dulbecco's
modiﬁed Eagle's medium (DMEM, Hyclone) supplemented with 10%
(v/v) heat-inactivated fetal bovine serum (FBS, Gibco) and 100 U/ml
penicillin and streptomycin. The HeLa cells and peritoneal macro-
phages were cultured in RPMI-1640 medium supplemented with
10% (v/v) FBS and 100 U/ml of penicillin and streptomycin. The
following antibodies were used: rabbit anti-IκBα (9242), rabbit anti-
p38 (9212), rabbit anti-phospho Erk1/2 (9101), rabbit anti-phospho
p38 (9215) and rabbit anti-phospho Jnk (9251, all from Cell Signaling
Technology); monoclonal mouse anti-TRAF6 (sc-8409) and rabbit
anti-TRAF6 (sc-7221, both from Santa Cruz Biotechnology); rabbit
anti-SHP-2 (ab10555, from Abcam); monoclonal mouse anti-Flag
M2 Afﬁnity Gel (A2220), rabbit anti-HA (H6908) and rabbit anti-
Flag (F7425, all from Sigma); Protein G Sepharose™ 4 Fast Flow (GE
Healthcare).
2.2. Plasmids and plasmid construction
The cDNA constructs encoding the EPEC (JPN15) Tir and EHEC
(EDL933) Tir (from J. Leong at the University of Massachusetts Medical
School) and the cDNA encoding EBV LMP2A (from R. Longnecker at
Northwestern University) were cloned into the Flag-pcDNA3 vector.a
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Fig. 1. Interaction of Tir with SHP-2. (a, b, c) Immunoprecipitation (IP) and immunoblot (IB)
Tir, EHEC Tir, LMP2A or SHP-2 performed using antibodies to either hemagglutinin (HA) or
indicated bacterial strains. (e) Immunoassay of Raw264.7 cells infected with either the JPN
independent experiments.The cDNA encoding SHP-2 was cloned into either the HA–pcDNA3 or
the Flag–pcDNA3 expression vector to generate the SHP-2 expression
constructs. All the constructs were veriﬁed byDNA sequencing analysis.
2.3. Mouse strains and bacterial growth
C57BL/6J mice were bred in speciﬁc pathogen-free conditions at
the Shanghai Research Center for Biomodel Organisms. All animal
studies were approved by the Institutional Animal Care and Use
Committee of the Shanghai Institutes for Biological Sciences (Chinese
Academy of Sciences).
The site-directed point mutagenesis of the HA-tagged EPEC Tir was
performed by PCR as described previously [11]. EPEC and itsΔTir strains
were cultured at 37 °C in Luria–Bertani (LB) media supplemented
with 100 μg/ml of ampicillin for 8 h. The pK184-based Tir plasmids
were propagated in bacteria in media supplemented with 25 μg/ml
of kanamycin. Before infection of host cells, EPEC were cultured in
DMEM + 10 mM HEPES (pH 7.4) in 5% CO2 for 15 h as previously
shown [12].
2.4. RT-PCR analysis
The cells were incubated for 12 h without serum and were
infected with bacteria for the indicated time. Total RNA was extracted
with 1 ml of TRIzol reagent according to the manufacturer's instruc-
tions (Invitrogen). Next, 1 μg of total RNA was reverse transcribedOverlay
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analysis of cell lysates from HEK293T cells transfected with the Flag- or HA-tagged EPEC
Flag. (d) Confocal view of HeLa cells transfected with Flag–SHP-2 and infected with the
15 ΔTir or the JPN15 (ΔTir + HA–Tir) strains. Data are representative of at least three
1889D. Yan et al. / Cellular Signalling 25 (2013) 1887–1894using the ReverTra Ace® qPCR RT Kit (Toyobo, FSQ-101) according to
the manufacturer's instructions. A LightCycler (Roche, LC480) and a
SYBR RT-PCR kit (Toyobo, QPK-212) were used for quantitative
real-time RT-PCR analysis. Expression values were normalized to
those obtained with the control gene Gapdh (encoding GAPDH).
2.5. Transfection and RNA interference
The siRNA targeting endogenous SHP-2 were transfected into
RAW264.7 cells using Amaxa program D-032 and the Cell Line
Nucleofector Kit V with the Amaxa Nucleofector apparatus (Amaxa
Biosystems) according to the manufacturer's instructions [13]. The
SHP-2 targeting sequences were as following: #1 5′-GAGGGAAGAG
CAAAUGUGUCAAGUA-3′; #2 5′-AAGUAUUCCUUGGUGGACCAGACAA-3′
[14]; the “nonsense” sequence (5′-UUCUCCGAACGUGUCACGUTT-3′)
was used as a control siRNA.
2.6. Pervanadate treatment and immunoprecipitation
For immunoprecipitation, HEK293T cellswere transiently transfected
with the indicated expression plasmids using the calcium phosphate–
DNA co-precipitation method. 48 h later, the cells were treated with
pervanadate (0.1 mM sodium orthovanadate and 10 mM H2O2)
for 30 min at 37 °C, washed with PBS, and subsequently lysed in
lysis buffer (20 mM Tris at pH 7.5, 150 mM NaCl, 1% Triton X-100,
sodium pyrophosphate, β-glycerophosphate, EDTA, Na3VO4, leupeptin)a
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Fig. 2. ITIM phosphorylation-dependent interaction of the Tir with SHP-2. (a) A schematic of
and various Tir ITIM mutants; (c) GST fusion mutants of Tir. p-Y and Yp indicate phosphory
tants puriﬁed from TKB1 bacteria. (e, f) GST precipitation assay of GST–Tir or its ITIM mutan
representative of at least three independent experiments.supplemented with 1% protease inhibitor cocktail (Sigma, P8340),
1 mM NaF and 1 mM Na3VO4. For the control sample, we omitted
the pervanadate treatment. After 30 min on ice, the lysates were
centrifuged for 15 min at 13,523 ×g at 4 °C to remove debris. The
cell lysates were incubated with anti-Flag M2 Afﬁnity Gel overnight
at 4 °C. For the endogenous immunoprecipitation, the RAW264.7
cells were infected with either the JPN15 ΔTir strain or the JPN15
ΔTir + HA–Tir strain for 6 h. The cells were subsequently lysed, and
the lysate was incubated with mouse anti-HA antibody and Protein G
Sepharose™ 4 Fast Flow overnight at 4 °C. The Sepharose samples
were centrifuged, washed three times with cell lysis buffer and boiled
with SDS loading buffer for 5 min.2.7. GST fusion proteins and precipitation assay
The Tir and SHP-2 encoding DNA sequences were ampliﬁed by PCR
and were subcloned into the pGEX-4T1 vector (Amersham) and the
pET28a (Novogen) vector, respectively. The site-directed point mutagen-
esis of GST–Tir was performed by PCR as described above. The His and
GST fusion proteins were expressed in BL-21(DE3) bacteria (Invitrogen)
or Escherichia coli (TKB1; Stratagene), respectively, according to the
manufacturer's instructions. The RAW264.7 cells were lysed as described
above. The lysates or puriﬁedHis–SHP-2proteinwere incubated for 4 h at
4 °Cwith equal amounts of the appropriate fusion protein coupled to glu-
tathione beads. The beadswere isolated by centrifugation,washed, boiled
with SDS loading buffer for 5 min, and later analyzed by immunoblot.FALL
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Tir ITIMmutants. (b) Immunoassay of cell lysates from HEK293T cells expressing SHP-2
lated tyrosine. (d) Tyrosine phosphorylation detection of GST fusion Tir or its ITIM mu-
ts with puriﬁed His–SHP-2 (e) or endogenous SHP-2 from Raw264.7 cells (f). Data are
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The indicated plasmids were transfected into HeLa cells with
Lipofectamine™ 2000 (11668-019, Invitrogen) according to the
manufacturer's instructions. 48 h after transfection, the cells were
infected with the JPN15 ΔTir + HA–Tir strain or the JPN15 ΔTir strain
for 4 h and then ﬁxed with 4% formaldehyde for 30 min at 25 °C. The
cells were stained and visualized under a Leica confocal microscope
equipped with analytical software as described previously.
3. Results
3.1. EPEC Tir interacts with SHP-2
The EPEC Tir contains two ITIM-like regions at its C-terminus
[8]. Our previous results have demonstrated that EPEC Tir interactsa
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(g) Immunoassay of cell lysates from HEK293T cells expressing SHP-2 and various TRAF6 dwith SHP-1 [15]. The cellular ITIM-containing proteins usually recruit
SHPs to inhibit immune responses [16,17]. To examine whether the
EPEC Tir interacts with SHP-2, Flag-tagged EPEC Tir and hemaggluti-
nin (HA)-tagged SHP-2 proteins were co-transfected into HEK293T
cells for co-immunoprecipitate assay. The EPEC Tir and SHP-2 were
found to co-immunoprecipitate in the presence of the phosphatase
inhibitor pervanadate (Fig. 1a), indicating that EPEC Tir interacts
with SHP-2. Two other ITIM-containing proteins, the EHEC Tir and
Epstein–Barr virus (EBV) LMP2A, were also found to immunopre-
cipitate with SHP-2 (Fig. 1b,c), which suggest that the interaction
between pathogen proteins and SHP-2 is a general mechanism. Next
we examined the intracellular localization of EPEC Tir and SHP-2 by
confocal microscopy in the context of EPEC infection. HeLa cells ex-
pressing Flag–SHP-2 were infected with either the JPN15 ΔTir strain,
a mutant strain of JPN15/pMAR7 (an Ampicillin resistant (Ampr) de-
rivative of EPEC O127:H6 strain E2348/69) in which the Tir is deleted,c
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eletion mutants. Data are representative of at least three independent experiments.
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with an HA-tagged Tir encoded by the pK184 vector to examine
the intracellular localization of the EPEC Tir and SHP-2. The HA–Tir
and Flag–SHP-2 were shown to signiﬁcantly co-localize with each
other under the immunoﬂuorescence confocal microscopy (Fig. 1d).
The interaction between the EPEC Tir and endogenous SHP-2 was
further examined in RAW264.7 cells that had been infected with
either the JPN15ΔTir strain or the JPN15 (ΔTir + HA–Tir) strain with
co-immunoprecipitate assay, as expected, the Tir was found to associ-
ate with endogenous SHP-2 (Fig. 1e). Thus, all the data presented here
demonstrated that SHP-2 can interact with Tir.SHP-2
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amount. (c) Immunoassay of HEK293T cells expressing the indicated vectors. (d) Immunoa
and IB of cell lysates from siRNA-treated RAW264.7 cells infected for indicated times with e
toneal macrophage cells infected for indicated times with the indicated strains. Data are re3.2. Tir-SHP-2 interaction requires ITIM phosphorylation
Signal transduction by ITIM containing proteins of immune cells
depends on the phosphorylation of its two ITIMs, and subsequent
recruitment of SHP-2 [8]. To investigate whether ITIM motifs of
microbial proteins need to be phosphorylated for its interaction
with SHP-2, we generated Tir mutants in which the tyrosine residues
of two ITIM motifs were replaced with phenylalanine individually
and together (Fig. 2a) and transfect them together with SHP-2 in
HEK293T cells. The data showed that substitution of Tyr483 resulted
in a little less binding of EPEC Tir to SHP-2, while substitution ofc
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teraction of EPEC Tir with SHP-2 is dependent on the phosphorylation
of ITIM of Tir, especially Tyr511. Next, we used E. coli with an induc-
ible tyrosine kinase gene and induced the bacteria to express either
phosphorylated recombinant wild-type EPEC Tir or its point mutants,
then puriﬁed the recombinant proteins as glutathione S-transferase
(GST) fusion proteins to determine whether ITIM phosphorylation
was required for direct interaction between Tir and SHP-2. Using these
puriﬁed recombinant proteins in an in vitro glutathione S-transferase
(GST) precipitation assay, We found that only the EPEC Tir protein
that possessed phosphorylated tyrosine-containing ITIMs could associ-
ate with puriﬁed recombinant His–SHP-2 or endogenous SHP-2 from
RAW264.7 cells and that mutating the tyrosine residues in the ITIMs
eliminated this association (Fig. 2d-f), especially Tyr511. Indeed, substi-
tution of Tyr483 resulted in a little less binding of EPEC Tir to SHP-2,
while substitution of Tyr511 resulted inmuch less binding and substitu-
tion of both ITIMs almost eliminated the binding, suggesting that the in-
teraction of EPEC Tir with SHP-2 is dependent on the phosphorylation
of ITIM of Tir, especially Tyr511. Taken together, these results suggest
that the direct interaction of Tir with SHP-2 is dependent on its tyrosine
phosphorylation of ITIMs.
3.3. SHP-2 can directly interact with TRAF6
To ﬁnd out which signaling pathways SHP-2 down-regulates to
inhibit cytokine production during EPEC infection, we investigated
whether SHP-2 interact with TRAF6, an important adaptor protein
of TLR4 signaling pathway [18–20]. Flag–TRAF6 and HA–SHP-2a
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Fig. 5. Inhibition of cytokine production via SHP-2. (a) Immunoblot of lysates isolated from
titative RT-PCR of Tnf and Il6 mRNA in siRNA-treated Raw264.7 cells after infection with
RAW264.7 cells after infected for indicated times with either the JPN15 or the JPN15 ΔTir s
of at least three independent experiments (mean and s.e.m. in b, c, e and f).were co-transfected into HEK293T cells, we found that TRAF6 immu-
noprecipitated together with SHP-2 (Fig. 3a), suggesting that SHP-2
interacts with TRAF6. In addition, we also examined the interaction
of SHP-2 with other TRAFs and the results showed that TRAF6, but not
TRAF2, immunoprecipitated with SHP-2 (Fig. 3b). To exam whether
SHP-2 can directly interact with TRAF6, we therefore performed pull-
down assays using the recombinant His–SHP-2 fusion protein and
GST–TRAF6 fusion protein. The anti-GST pull-down assay showed that
GST–TRAF6 immunoprecipitated with puriﬁed recombinant His–
SHP-2 (Fig. 3c), but GST cannot, indicating that SHP-2 can directly inter-
act with TRAF6. Similarly, TRAF2 didn't interact with SHP-2 directly
(Fig. 3d,e). Collectively, these results demonstrated that TRAF6 interacts
with SHP-2 directly. We made deletion mutants of TRAF6 (Fig. 3f)
and assessed whether these mutants retained their ability to interact
with SHP-2 to map the region of TRAF6 protein that binds to SHP-2.
The TRAF6 fragments containing amino acid residues 107–523 and
1–273 decreased the ability to bind to SHP-2, while residues 274–523
almost abolished this binding. In fact, SHP-2 bound only to the region
of TRAF6 corresponding to amino acid residues 1–358 (Fig. 3g). Thus,
residues 107–358 are essential for the binding of TRAF6 and SHP-2.
3.4. Tir enhances the binding of SHP-2 with TRAF6 to decrease TRAF6
ubiquitination
It is known that TRAF6 activation depends on its auto-ubiquitination
and that deubiquitination of TRAF6blocks downstream signaling events
[21–23]. To detect if SHP-2 interferes with the autoubiquitination
of TRAF6, we transfected Flag-tagged TRAF6 together with HA-taggedc
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of TRAF6 by western blotting. We found that ectopic expression of
SHP-2 in HEK293T cells signiﬁcantly decreased the ubiquitination
of TRAF6 in a dose dependent manner (Fig. 4a) but not of TRAF2
(Fig. 4b). Further, overexpression of the EPEC Tir in HEK293T cells
enhanced the interaction of TRAF6 and SHP-2 (Fig. 4c). Furthermore,
we found that the enhanced interaction of SHP-2 and TRAF6 in prima-
ry peritoneal macrophage cells exclusively occurred when cells were
infected with JPN15 (ΔTir + HA–Tir) strains, but not JPN15 ΔTir
strains (Fig. 4d), suggesting that Tir could enhance the interaction of
SHP-2 with TRAF6 in bacterial infectious conditions. Next, we detected
the effect of SHP-2 on TRAF6 ubiquitination for endogenous proteins.
As expected, Ctrl siRNA-transfected RAW264.7 cells infected with
JPN15 strain showed much less ubiquitination than that of JPN15 ΔTir
strain, suggesting that Tir can inhibit the bacterial infection induced
TRAF6 ubiquitination. However, transfection of RAW264.7 cells with
SHP-2 siRNA substantially enhanced the ubiquitination of TRAF6 upon
JPN15 infection, especially 3 h after infection, whereas there is no sig-
niﬁcant difference on the ubiquitination of TRAF6 when infected with
JPN15 ΔTir strains (Fig. 4e). Similarly, JPN15 (ΔTir + HA–Tir) strains
inhibited the ubiquitination of TRAF6 compared to JPN15 ΔTir strains
(Fig. 4f).
3.5. Tir inhibits EPEC infection induced cytokine production via SHP-2
Since Tir interacts with SHP-2, we next investigated whether Tir in-
hibits the cytokine production through SHP-2. Non-targeting control
small interfering RNA (Ctrl siRNA) or two pairs of SHP-2 siRNAwere in-
troduced into RAW264.7 cells. Western blotting assay was performed
to determine the SHP-2 knockdown efﬁciency, and the data showed
that SHP-2-speciﬁc siRNA could signiﬁcantly decrease the expression
of SHP-2 (Fig. 5a). As expected, Ctrl siRNA-transfected RAW264.7 cells
infected with JPN15 strain produced much less Tnf or Il-6 than that of
JPN15 ΔTir strain, suggesting that Tir can inhibit the bacterial infection
induced host immune response. However, transfection of RAW264.7
cells with SHP-2 siRNA substantially enhanced the expression of Tnf or
Il-6 upon JPN15 infection, whereas there is no signiﬁcant difference on
the expression of Tnf or Il-6 when infected with JPN15 ΔTir strains
(Fig. 5b,c). To dissect the signal pathways inhibited by Tir-SHP-2
axis. The RAW264.7 cells were transfected with either Ctrl siRNA or
SHP-2 siRNA 2. 48 h later, the cells were infected with either the
JPN15 or JPN15 ΔTir strain, and the activation of the MAP kinase and
NF-κB signaling pathways was analyzed to examine whether SHP-2
mediated Tir inhibitedMAP kinase andNF-κB pathways.When infected
with JPN15 strain, the infection of Ctrl siRNA treated RAW264.7 cells
induced the phosphorylation of Jnk, Erk, p38, and the degradation of
the upstream NF-κB regulator IκBα. Importantly, these effects were
more striking in cells treated with SHP-2 siRNA, especially at 3 h
post-infection, when the insertion of the Tir protein into the host cell
membrane is probably at its peak. However, 48 h after RAW264.7
cells were transfected with either Ctrl siRNA or SHP-2 siRNA, there is
no signiﬁcant difference on the signal pathways when infected with
JPN15 ΔTir strains (Fig. 5d). Thus, all the results demonstrated that
SHP-2 is required for the EPEC Tir-mediated inhibition of cytokine
production and signal transduction (Fig. 6).
4. Discussion
EPEC infections usually cause unexpected low inﬂammation,
suggesting that the pathogen may develop some strategies to inter-
fere with the host inﬂammatory pathways [24]. During infection,
T3SS delivery system of EPEC transfers numerous ‘effector’ proteins
directly into host cells to interfere with different cellular functions
[25]. EPEC Tir is the only effector shown to be essential for disease
development [26,27]. However, relatively little is known about how
the Tir regulates the innate inﬂammatory responses. As has beenreported before, some pathogen proteins also contain ITIM motifs
[8]. Our previous results have demonstrated that Tir from EPEC
could interact with the cellular tyrosine phosphatase SHP-1 in an
ITIM phosphorylation-dependent manner. The association of the
Tir with SHP-1 facilitated the recruitment of SHP-1 to TRAF6 and
inhibited the ubiquitination of TRAF6 and downstream cytokine
production [15]. The cytoplasmic tyrosine phosphatases, SHP-1 and
SHP-2, are implicated and play the same role in the control of immune
response in many cases [28]. Here, we identify SHP-2 as another host
protein that interacts with Tir to suppress the host cytokine produc-
tion, and determine that binding of SHP-2 with Tir is dependent on
ITIM phosphorylation. Furthermore, interaction of SHP-2 with Tir
increases the recruitment of SHP-2 to TRAF6, and “knockdown” of
SHP-2 by RNAi decreases the Tir-mediated inhibitory signaling and in-
hibition of cytokine production. Thus, in addition to SHP-1 [15], SHP-2
emerges as another novel molecule in the regulation of bacterial pro-
tein mediated inhibitory signaling. However, the manner in which the
complex of SHP-1, SHP-2 and Tir coordinates to negatively regulate
cytokine production needs further investigation.
ITIM-like motifs are a notable feature of the Tir protein and are
shown here to be essential for its interaction with SHP-2, and thus,
its ability to inhibit host cytokine production. Other microbial pro-
teins also contain ITIM motifs, and we have shown that at least
two other ITIM-containing proteins, EHEC Tir and EBV LMP2A,
co-immunoprecipitate with SHP-2. Thus, the utilization of cellular
ITIM-like motifs by microbial proteins to interfere with host immune
responses could be a general mechanism by which microbial patho-
gens establish successful infection.
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